triiodothyronine has been researched along with n,n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksoy, O; Balber, T; Baltzer, PA; Culig, Z; Egger, G; Greiner, G; Hacker, M; Haitel, A; Hartenbach, M; Hartenbach, S; Hassler, MR; Heery, DM; Herac, M; Hoermann, G; Kenner, L; Kramer, G; Marculescu, R; Mazumder, B; Merkel, O; Mitterhauser, M; Moazzami, AA; Moriggl, R; Neubauer, HA; Oppelt, J; Pencik, J; Philippe, C; Pospisilova, S; Roberts, CJ; Schlederer, M; Shariat, SF; Stangl-Kremser, J; Susani, M; Tangermann, S; Tichy, B; Turner, SD; Varady, A; Whitchurch, JB | 1 |
1 other study(ies) available for triiodothyronine and n,n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium
| Article | Year |
|---|---|
Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
Topics: Cell Line, Tumor; Choline; Cohort Studies; Crystallins; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Metabolomics; mu-Crystallins; Neoplasm Staging; PC-3 Cells; Positron Emission Tomography Computed Tomography; Prognosis; Prostatic Neoplasms; Receptors, Androgen; Receptors, Thyroid Hormone; Sequence Analysis, RNA; Signal Transduction; Tissue Array Analysis; Triiodothyronine | 2021 |